ArticleBritish journal of cancer2024

Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial.

Hans-Joachim Schmoll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.